Article Type
Changed
Fri, 02/15/2019 - 09:12
Display Headline
The evolving role of hormone therapy in advanced prostate cancer
Article PDF
Author and Disclosure Information

Robert Dreicer, MD
Director, Genitourinary Medical Oncology, Departments of Hematology and Medical Oncology and the Urological Institute, Cleveland Clinic

Address: Robert Dreicer, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; dreicer@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 67(10)
Publications
Topics
Page Number
720-722, 725-726
Sections
Author and Disclosure Information

Robert Dreicer, MD
Director, Genitourinary Medical Oncology, Departments of Hematology and Medical Oncology and the Urological Institute, Cleveland Clinic

Address: Robert Dreicer, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; dreicer@ccf.org

Author and Disclosure Information

Robert Dreicer, MD
Director, Genitourinary Medical Oncology, Departments of Hematology and Medical Oncology and the Urological Institute, Cleveland Clinic

Address: Robert Dreicer, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; dreicer@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(10)
Issue
Cleveland Clinic Journal of Medicine - 67(10)
Page Number
720-722, 725-726
Page Number
720-722, 725-726
Publications
Publications
Topics
Article Type
Display Headline
The evolving role of hormone therapy in advanced prostate cancer
Display Headline
The evolving role of hormone therapy in advanced prostate cancer
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media